International CRDS Registry for Calcium Release Deficiency Syndrome
International CRDS Registry
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Population Health Research Institute · Other
This trial is looking for people with a specific rare genetic change related to Calcium Release Deficiency Syndrome (CRDS). Taking part involves providing information about your condition and possibly undergoing further testing.
You may be able to join if
- I have a rare RYR2 variant that is known to cause issues based on lab testing.
- I have a rare RYR2 truncating variant or a large change in the RYR2 gene.
- I have a rare RYR2 variant that is neither causing problems nor improving function based on lab testing.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityCalcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypic spectrum, approaches to risk stratification, and optimal treatment strategies.
Loading trial locations…